Atezolizumab
RxNorm 1792776
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1792776 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: atezolizumab.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Ingredient (IN):
Atezolizumab
(Atom ID: 8219968)
Designated preferred name (PT):
Atezolizumab
(Atom ID: 8718131)
Full form of descriptor (FN):
Atezolizumab (substance)
(Atom ID: 8718132)
Designated preferred name (PT):
Atezolizumab-containing product
(Atom ID: 10797248)
Full form of descriptor (FN):
Product containing atezolizumab (medicinal product)
(Atom ID: 10304493)
Patient Education
Atezolizumab Injection
Atezolizumab injection is used: to treat certain types of urothelial cancer (cancer of the lining of the bladder and other parts of the urinary tract) that has spread or cannot be removed by surgery in people unable to receive platinum-containing chemotherapy (carboplatin, cisplatin), alone or with other chemotherapy medications as a first treatment for certain types of non-small cell lung cancer (NSCLC) that has spread to other parts of the body, to treat a certain type of NSCLC that has spread to other parts of the body and that has worsened during or after treatment with other chemotherapy medications, together with other chemotherapy medications as a first treatment for a certain type of small cell lung cancer (SCLC) that has spread throughout the lung or to other parts of the body, together with other chemotherapy medications as a treatment for a certain type of breast cancer that has spread to other parts of the body or cannot be removed by surgery, in combination with bevacizumab (Avastin) to treat hepatocellular carcinoma (HCC) that has spread or cannot be removed by surgery in people who have not previously not received chemotherapy, and in combination with cobimetinib (Cotellic) and vemurafenib (Zelboraf) to treat certain types of melanoma (a type of skin cancer) that has spread or cannot be removed by surgery. Atezolizumab injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain protein in cancer cells. This helps the person's immune system to fight against the cancer cells, and helps to slow tumor growth.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
